Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Ikena Oncology, Inc. (IMA) had Return on Tangible Equity of -2.39% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.77M |
|
-- |
|
-- |
|
$8.75M |
|
$-8.75M |
|
$6.00M |
|
$-2.75M |
|
$-2.75M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-8.75M |
|
$-8.91M |
|
4.02M |
|
4.02M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$99.01M |
|
$0.42M |
|
$27.15M |
|
$126.17M |
|
$7.32M |
|
-- |
|
$2.94M |
|
$10.26M |
|
$115.91M |
|
$115.91M |
|
$115.91M |
|
4.02M |
|
| Cash Flow Statement Financials | |
$-13.98M |
|
$32.88M |
|
-- |
|
$40.27M |
|
$59.16M |
|
$18.90M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.39% |
|
|
Return on Tangible Equity |
-2.39% |
-2.19% |
|
-2.39% |
|
$28.83 |
|
$-3.48 |
|
$-3.48 |
|